http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DO-P2011000373-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
filingDate 2011-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54de616eb4fced3aba4b52d56c6dfb09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37381607ef6983f4128d52031eb4b92c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52e61a3cb6c0188aba6c35f111c0d53f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b2b48cb07d743e66c6dcaf8a6d6a882
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1454fc74b644247baeb1914f97a5f577
publicationDate 2011-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DO-P2011000373-A
titleOfInvention DERIVATIVES OF 1H-IMIDAZO- [4,5-C] -QUINOLINONA
abstract The invention relates to the use of 1H-imidazo- [4,5- c] -quinolinone derivatives and salts thereof in the treatment of diseases dependent on protein or lipid kinase and for the preparation of pharmaceutical preparations for the treatment of these diseases; to derivatives of IH-imidazo- [4,5-cJ-quinolinone for use in the treatment of protein or lipid kinase dependent diseases; to a method for the treatment against these diseases, which comprises administering the derivatives of IH-imidazo- [4,5-c] -quinolinone to a warm-blooded animal, especially a human being; to pharmaceutical preparations comprising a derivative of 1H-imidazo- [4,5-c] -quinolinone, especially for the treatment of a disease dependent on protein kinase and lipid; to the novel IH-imidazo- [4,5-c] -quinolinone derivatives; and to a process for the preparation of novel 1H-imidazo- [4,5-c] -quinolinone derivatives.
priorityDate 2009-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12913176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419876795

Total number of triples: 29.